The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of standard of care (SOC) ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM).
 
Doris K. Hansen
Consulting or Advisory Role - Bristol Myers Squibb Foundation
Research Funding - Bristol-Myers Squibb/Celgene
 
Krina K. Patel
Consulting or Advisory Role - Arcellx; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Cellectis; Janssen; Karyopharm Therapeutics; Merck; Pfizer; Takeda; Takeda
Research Funding - Abbvie/Genentech; Allogene Therapeutics; Celgene/Bristol-Myers Squibb; Cellectis; Janssen; Nektar; Poseida; Precision Biosciences; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Lauren C. Peres
Research Funding - Bristol Myers Squibb Foundation (Inst)
 
Mehmet H. Kocoglu
Research Funding - Abbvie/Genentech (Inst); BMS (Inst); Genentech (Inst); GlaxoSmithKline (Inst); janssen (Inst); Poseida (Inst)
 
Leyla Shune
No Relationships to Disclose
 
Gary Simmons
Speakers' Bureau - Kite, a Gilead company
 
Christopher J. Ferreri
Stock and Other Ownership Interests - Affimed Therapeutics
Consulting or Advisory Role - Sanofi
 
Shebli Atrash
Honoraria - Janssen
Research Funding - Amgen; Celgene/Bristol-Myers Squibb (Inst); GlaxoSmithKline; Janssen Oncology (Inst); Karyopharm Therapeutics
 
Ricardo Daniel Parrondo
No Relationships to Disclose
 
Saurabh Chhabra
Honoraria - GlaxoSmithKline; Janssen Oncology; Sanofi
Research Funding - C4 Therapeutics; CARsgen Therapeutics; Janssen
 
Patrick Costello
No Relationships to Disclose
 
Shonali Midha
No Relationships to Disclose
 
Melissa Alsina
Honoraria - Janssen
Consulting or Advisory Role - BMS; Janssen Oncology
Speakers' Bureau - Janssen Oncology
 
Peter M. Voorhees
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Sanofi
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline
 
Myo Htut
Consulting or Advisory Role - Millennium
Research Funding - BMS (Inst); Judy and Bernard Briskin Center for Multiple Myeloma Research (Inst)
Travel, Accommodations, Expenses - Millennium
 
Douglas W. Sborov
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Legend Biotech; Pfizer; Sanofi; Skyline Diagnostics
 
Jack Khouri
No Relationships to Disclose
 
Murali Janakiram
No Relationships to Disclose
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Pfizer (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Surbhi Sidana
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen; Magenta Therapeutics; Oncopeptides; Sanofi
Research Funding - Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Magenta Therapeutics (Inst)